Oncology, derm / cosmetics
Total Trials
9
As Lead Sponsor
2
As Collaborator
7
Total Enrollment
2,366
NCT00709579
Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids
Phase: Phase 3
Role: Collaborator
Start: Jun 30, 2008
Completion: Aug 31, 2010
NCT04605900
Impact of Therapeutic Footwear and Plantar Orthoses on Diabetic Neuropathic Foot in Quality of Life and Functionality
Phase: N/A
Start: Mar 13, 2017
Completion: May 21, 2018
NCT04045691
Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
Start: Oct 17, 2019
Completion: Sep 30, 2027
NCT04388384
Real-life Pan-HER-blockade With Neratinib
Start: Jul 2, 2020
Completion: Sep 5, 2024
NCT04318405
Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE).
Role: Lead Sponsor
Start: Jul 10, 2020
Completion: Nov 30, 2022
NCT04673955
BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment
Start: Sep 3, 2020
Completion: Jan 31, 2027
NCT06332443
Randomized, Controlled Trial Comparing the Effectiveness of Sedation-Epidural Anesthesia to Spinal Anesthesia in Outpatient Hip or Knee Arthroplasty.
Start: Mar 15, 2023
Completion: Mar 15, 2026
NCT06422715
PTLD: Multicentric Retrospective Study
Start: Jul 31, 2024
Completion: Jan 31, 2026
NCT07022457
UK ENcorafenib and BInimetinib Real-world Study in Melanoma
Start: Jul 31, 2025
Completion: Jan 13, 2028
Loading map...